TY - CHAP
T1 - Toxicokinetics and Safety Ratios
AU - Sombogaard, Ferdi
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Pharmacokinetics is essentially the study of “how a substance gets into the body and what happens to it in the body.” Similarly, toxicokinetics deals with what the body does with a drug or other substance when given a relatively high dose relative to the therapeutic dose. Toxicokinetic studies are generally carried out at much higher doses than those used in pharmacokinetic studies, and this dose information is critical for predicting the safety of substances. The primary objective of toxicokinetics is to describe the systemic exposure achieved in animals and its relationship to dose level and the time course of the toxicity study. The ratio of drug exposure in animals at the no observed adverse effect level (NOAEL) and in humans at the expected therapeutic dose is one of the precautionary principles to determine the risk benefit profile of pharmaceuticals.
AB - Pharmacokinetics is essentially the study of “how a substance gets into the body and what happens to it in the body.” Similarly, toxicokinetics deals with what the body does with a drug or other substance when given a relatively high dose relative to the therapeutic dose. Toxicokinetic studies are generally carried out at much higher doses than those used in pharmacokinetic studies, and this dose information is critical for predicting the safety of substances. The primary objective of toxicokinetics is to describe the systemic exposure achieved in animals and its relationship to dose level and the time course of the toxicity study. The ratio of drug exposure in animals at the no observed adverse effect level (NOAEL) and in humans at the expected therapeutic dose is one of the precautionary principles to determine the risk benefit profile of pharmaceuticals.
UR - https://www.scopus.com/pages/publications/85161956161
UR - https://www.ncbi.nlm.nih.gov/pubmed/37313297
U2 - 10.1007/978-3-319-68864-0_21
DO - 10.1007/978-3-319-68864-0_21
M3 - Chapter
C2 - 37313297
SN - 9783319688633
T3 - Drug Discovery and Evaluation: Methods in Clinical Pharmacology, Second Edition
SP - 949
EP - 956
BT - Drug Discovery and Evaluation: Methods in Clinical Pharmacology, Second Edition
PB - Springer International Publishing
ER -